We are live on ! Find out more
ORI

Oak Ridge Investments Portfolio holdings

AUM $1.77B
1-Year Est. Return 63.16%
This Fund
S&P 500
This Quarter Est. Return
+46.44%
1 Year Est. Return
+63.16%
3 Year Est. Return
+207.98%
5 Year Est. Return
+285.85%
10 Year Est. Return
+1,406.08%
AUM
$1.77B
AUM Growth
+$256M
Cap. Flow
-$60.9M
Cap. Flow %
-3.45%
Top 10 Hldgs %
50.33%
Holding
201
New
20
Increased
74
Reduced
75
Closed
31

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$79.7M
2
AAPL icon
Apple
AAPL
+$68.5M
3
AMZN icon
Amazon
AMZN
+$61.9M
4
NFLX icon
Netflix
NFLX
+$20.4M
5
ORCL icon
Oracle
ORCL
+$17.1M

Sector Composition

Rank Sector Weight
1 Technology 51.08%
2 Communication Services 14.26%
3 Industrials 10.5%
4 Healthcare 10.11%
5 Consumer Discretionary 7.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDCC icon
76
InterDigital
IDCC
$6.68B
$3.77M 0.21%
13,326
+5,107
+62% +$1.52M
CRWV
77
CoreWeave
CRWV
$39.2B
$3.65M 0.21%
36,623
+43
+0.1% +$4.64K
CWST icon
78
Casella Waste Systems
CWST
$5.69B
$3.61M 0.2%
37,277
+724
+2% +$61.9K
AXSM icon
79
Axsome Therapeutics
AXSM
$12.4B
$3.58M 0.2%
14,619
+407
+3% +$88.3K
HOOD icon
80
Robinhood
HOOD
$85.2B
$3.44M 0.19%
34,346
+339
+1% +$28.4K
HALO icon
81
Halozyme
HALO
$9.72B
$3.41M 0.19%
43,515
+3,345
+8% +$228K
URGN icon
82
UroGen Pharma
URGN
$2B
$3.26M 0.18%
88,591
+2,188
+3% +$59.3K
CORT icon
83
Corcept Therapeutics
CORT
$10.2B
$2.97M 0.17%
34,172
+9,302
+37% +$562K
TVTX icon
84
Travere Therapeutics
TVTX
$5.33B
$2.97M 0.17%
52,234
-15,089
-22% -$669K
IRMD icon
85
iRadimed
IRMD
$1.21B
$2.88M 0.16%
30,172
+743
+3% +$67.7K
POWL icon
86
Powell Industries
POWL
$8.46B
$2.88M 0.16%
10,045
-18,494
-65% -$5.02M
BBIO icon
87
BridgeBio Pharma
BBIO
$16.5B
$2.84M 0.16%
38,190
+298
+0.8% +$20.9K
AIR icon
88
AAR Corp
AIR
$5.15B
$2.83M 0.16%
19,810
+496
+3% +$58.6K
SAIA icon
89
Saia
SAIA
$11.3B
$2.82M 0.16%
6,694
+133
+2% +$58.4K
FCFS icon
90
FirstCash
FCFS
$8.55B
$2.82M 0.16%
13,022
+331
+3% +$71.9K
MWA icon
91
Mueller Water Products
MWA
$3.92B
$2.8M 0.16%
108,306
+2,097
+2% +$56.1K
CYTK icon
92
Cytokinetics
CYTK
$11B
$2.77M 0.16%
32,518
+16,616
+104% +$1.19M
LMAT icon
93
LeMaitre Vascular
LMAT
$2.18B
$2.68M 0.15%
27,970
+8,840
+46% +$906K
MIRM icon
94
Mirum Pharmaceuticals
MIRM
$6.89B
$2.62M 0.15%
22,408
+4,895
+28% +$491K
OLLI icon
95
Ollie's Bargain Outlet
OLLI
$4.01B
$2.61M 0.15%
33,886
-5,635
-14% -$470K
ARWR icon
96
Arrowhead Research
ARWR
$12.1B
$2.6M 0.15%
31,910
+796
+3% +$58.8K
UFPT icon
97
UFP Technologies
UFPT
$1.84B
$2.47M 0.14%
9,335
+214
+2% +$46.5K
DAVE icon
98
Dave Inc
DAVE
$5.12B
$2.38M 0.13%
+6,389
New +$1.66M
TATT icon
99
TAT Technologies
TATT
$543M
$2.33M 0.13%
48,295
+18,255
+61% +$733K
XENE icon
100
Xenon Pharmaceuticals
XENE
$6.32B
$2.33M 0.13%
+38,559
New +$2.14M

Similar funds

Oak Ridge Investments's Q2 2026 Portfolio in Review

As of Q2 2026, Oak Ridge Investments held 201 positions worth $1.77B, up 17% from $1.51B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Oak Ridge Investments withdrew a net $60.9M in Q2 2026, closing 31 positions and reducing 75 holdings. Its most notable exit was Oracle, an estimated $17.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 51% of assets, up from 50% a quarter earlier, followed by Communication Services and Industrials.

Against the trend, Oak Ridge Investments opened a new position in Advanced Micro Devices worth $55.7M.

  • Oak Ridge Investments's largest Q2 2026 buy was Advanced Micro Devices: 95,932 shares worth $55.7M.
  • Oak Ridge Investments added most to Alphabet (Google) Class C in Q2 2026, an estimated $54.5M increase.
  • Oak Ridge Investments's biggest Q2 2026 reduction was Microsoft, cutting an estimated $79.7M.
  • Oak Ridge Investments fully exited Oracle in Q2 2026, selling an estimated $17.1M.
  • Oak Ridge Investments's ten largest holdings make up 50% of its $1.77B portfolio in Q2 2026.
  • Oak Ridge Investments opened 20 new positions and closed 31 in Q2 2026.
  • Oak Ridge Investments's portfolio value rose 17% quarter-over-quarter to $1.77B.

Based on Oak Ridge Investments's 13F filing for Q2 2026, filed 21 Jul 2026.